Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aharon G Freud

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Cancers|January 22, 2021
Unraveling the Role of Innate Lymphoid Cells in AcuteMyeloid LeukemiaMatthew R Lordo, Steven D Scoville, Akul Goel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancerManisha H Shah, Aharon G Freud, Don M Benson, et al.
International Journal of Cancer|December 13, 2016
Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomasBradley M Haverkos, Ying Huang, Alejandro Gru, et al.
Blood|February 27, 2009
Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22Tiffany Hughes, Brian Becknell, Susan McClory, et al.
Human Pathology|June 14, 2014
Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphomaRyan A Metcalf, Ahmad Monabati, Monika Vyas, et al.
Blood|December 9, 2008
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cellsDon M Benson, Jianhua Yu, Brian Becknell, et al.
Cancer Research|November 3, 2004
Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2Sameek Roychowdhury, Kenneth F May, Katherine S Tzou, et al.
Blood|June 25, 2005
IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host diseaseSameek Roychowdhury, Bradley W Blaser, Aharon G Freud, et al.
The Journal of Clinical Investigation|March 2, 2012
Evidence for a stepwise program of extrathymic T cell development within the human tonsilSusan McClory, Tiffany Hughes, Aharon G Freud, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteinsYinchong Wang, Evdokiya Reshetnikova, Nar B Katuwal, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Cancers|January 22, 2021
Unraveling the Role of Innate Lymphoid Cells in AcuteMyeloid LeukemiaMatthew R Lordo, Steven D Scoville, Akul Goel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancerManisha H Shah, Aharon G Freud, Don M Benson, et al.
International Journal of Cancer|December 13, 2016
Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomasBradley M Haverkos, Ying Huang, Alejandro Gru, et al.
Blood|February 27, 2009
Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22Tiffany Hughes, Brian Becknell, Susan McClory, et al.
Human Pathology|June 14, 2014
Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphomaRyan A Metcalf, Ahmad Monabati, Monika Vyas, et al.
Blood|December 9, 2008
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cellsDon M Benson, Jianhua Yu, Brian Becknell, et al.
Cancer Research|November 3, 2004
Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2Sameek Roychowdhury, Kenneth F May, Katherine S Tzou, et al.
Blood|June 25, 2005
IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host diseaseSameek Roychowdhury, Bradley W Blaser, Aharon G Freud, et al.
The Journal of Clinical Investigation|March 2, 2012
Evidence for a stepwise program of extrathymic T cell development within the human tonsilSusan McClory, Tiffany Hughes, Aharon G Freud, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteinsYinchong Wang, Evdokiya Reshetnikova, Nar B Katuwal, et al.
Pageof 9